Citation
Select
EMPA-REG OUTCOME Investigators; Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
N Engl J Med. 2015 Nov 26;373(22):2117-28
Citation
Select
Wright JT; SPRINT Research Group
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
N Engl J Med. 2015 Nov 26;373(22):2103-16